216 related articles for article (PubMed ID: 32143173)
1. Cytoplasmic expression of B7-H3 and membranous EpCAM expression are associated with higher grade and survival outcomes in patients with clear cell renal cell carcinoma.
Saeednejad Zanjani L; Madjd Z; Axcrona U; Abolhasani M; Rasti A; Asgari M; Fodstad Ø; Andersson Y
Ann Diagn Pathol; 2020 Jun; 46():151483. PubMed ID: 32143173
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A
BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma.
Saeednejad Zanjani L; Madjd Z; Abolhasani M; Andersson Y; Rasti A; Shariftabrizi A; Asgari M
Exp Mol Pathol; 2017 Oct; 103(2):218-228. PubMed ID: 29050853
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of Talin-1 in renal cell carcinoma and its association with B7-H3.
Saeednejad Zanjani L; Vafaei S; Abolhasani M; Fattahi F; Madjd Z
Cancer Biomark; 2022; 35(3):269-292. PubMed ID: 36245369
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD105 cancer stem cell marker in three subtypes of renal cell carcinoma.
Saeednejad Zanjani L; Madjd Z; Abolhasani M; Shariftabrizi A; Rasti A; Asgari M
Cancer Biomark; 2018; 21(4):821-837. PubMed ID: 29286924
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of caveolin-1 in renal neoplasms.
Tamaskar I; Choueiri TK; Sercia L; Rini B; Bukowski R; Zhou M
Cancer; 2007 Aug; 110(4):776-82. PubMed ID: 17594718
[TBL] [Abstract][Full Text] [Related]
7. Human telomerase reverse transcriptase protein expression predicts tumour aggressiveness and survival in patients with clear cell renal cell carcinoma.
Saeednejad Zanjani L; Madjd Z; Abolhasani M; Rasti A; Shariftabrizi A; Mehrazma M; Fodstad Ø; Asgari M
Pathology; 2019 Jan; 51(1):21-31. PubMed ID: 30466948
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma.
Crispen PL; Sheinin Y; Roth TJ; Lohse CM; Kuntz SM; Frigola X; Thompson RH; Boorjian SA; Dong H; Leibovich BC; Blute ML; Kwon ED
Clin Cancer Res; 2008 Aug; 14(16):5150-7. PubMed ID: 18694993
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.
Rasti A; Madjd Z; Abolhasani M; Mehrazma M; Janani L; Saeednejad Zanjani L; Asgari M
Clin Exp Med; 2018 May; 18(2):177-190. PubMed ID: 29204790
[TBL] [Abstract][Full Text] [Related]
10. Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumors.
Went P; Dirnhofer S; Salvisberg T; Amin MB; Lim SD; Diener PA; Moch H
Am J Surg Pathol; 2005 Jan; 29(1):83-8. PubMed ID: 15613858
[TBL] [Abstract][Full Text] [Related]
11. Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma.
Seligson DB; Pantuck AJ; Liu X; Huang Y; Horvath S; Bui MH; Han KR; Correa AJ; Eeva M; Tze S; Belldegrun AS; Figlin RA
Clin Cancer Res; 2004 Apr; 10(8):2659-69. PubMed ID: 15102668
[TBL] [Abstract][Full Text] [Related]
12. Epithelial cell adhesion molecule is an independent prognostic marker in clear cell renal carcinoma.
Eichelberg C; Chun FK; Bedke J; Heuer R; Adam M; Moch H; Terracciano L; Hinrichs K; Dahlem R; Fisch M; Schlomm T; Sauter G; Minner S
Int J Cancer; 2013 Jun; 132(12):2948-55. PubMed ID: 23180689
[TBL] [Abstract][Full Text] [Related]
13. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
Peng Y; Greenland NY; Lang UE; Stohr BA
Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
[TBL] [Abstract][Full Text] [Related]
14. Impact of an altered Wnt1/β-catenin expression on clinicopathology and prognosis in clear cell renal cell carcinoma.
Kruck S; Eyrich C; Scharpf M; Sievert KD; Fend F; Stenzl A; Bedke J
Int J Mol Sci; 2013 May; 14(6):10944-57. PubMed ID: 23708097
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of CXCR4, a novel renal cancer stem cell marker, is associated with high-grade renal cell carcinoma.
Rasti A; Abolhasani M; Zanjani LS; Asgari M; Mehrazma M; Madjd Z
J Cancer Res Clin Oncol; 2017 Jan; 143(1):95-104. PubMed ID: 27638770
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
Nofech-Mozes R; Khella HW; Scorilas A; Youssef L; Krylov SN; Lianidou E; Sidiropoulos KG; Gabril M; Evans A; Yousef GM
Cancer Med; 2016 Apr; 5(4):656-64. PubMed ID: 26860079
[TBL] [Abstract][Full Text] [Related]
18. B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer.
Ingebrigtsen VA; Boye K; Tekle C; Nesland JM; Flatmark K; Fodstad O
Int J Cancer; 2012 Dec; 131(11):2528-36. PubMed ID: 22473715
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic PAR-3 protein expression is associated with adverse prognostic factors in clear cell renal cell carcinoma and independently impacts survival.
Dagher J; Dugay F; Rioux-Leclercq N; Verhoest G; Oger E; Bensalah K; Cabillic F; Jouan F; Kammerer-Jacquet SF; Fergelot P; Vigneau C; Arlot-Bonnemains Y; Belaud-Rotureau MA
Hum Pathol; 2014 Aug; 45(8):1639-46. PubMed ID: 24856572
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]